Clinical Trial Update: Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating dose response of valsartan on sitting systolic blood pressure in children aged 6 months to 5 years with hypertension. Results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-05-09